Canada markets open in 1 hour 58 minutes

  • S&P/TSX

    18,421.60
    +121.98 (+0.67%)
     

  • S&P 500

    3,870.29
    -31.53 (-0.81%)
     

  • DOW

    31,391.52
    -143.99 (-0.46%)
     

  • CAD/USD

    0.7922
    +0.0009 (+0.12%)
     

  • CRUDE OIL

    60.68
    +0.93 (+1.56%)
     

  • BTC-CAD

    65,164.27
    +3,217.25 (+5.19%)
     

  • CMC Crypto 200

    1,030.09
    +41.99 (+4.25%)
     

  • GOLD FUTURES

    1,723.20
    -10.40 (-0.60%)
     

  • RUSSELL 2000

    2,231.51
    -43.81 (-1.93%)
     

  • 10-Yr Bond

    1.4150
    0.0000 (0.00%)
     

  • NASDAQ futures

    13,131.75
    +76.50 (+0.59%)
     

  • VOLATILITY

    22.97
    -0.38 (-1.63%)
     

  • FTSE

    6,665.97
    +52.22 (+0.79%)
     

  • NIKKEI 225

    29,559.10
    +150.93 (+0.51%)
     

  • CAD/EUR

    0.6563
    +0.0018 (+0.28%)
     

Brighthouse Financial Announces Conference Call to Discuss Fourth Quarter and Full Year 2020 Results

·1 min read

Brighthouse Financial, Inc. (Brighthouse Financial) (Nasdaq: BHF) announced today that it plans to hold a conference call and audio webcast to discuss its financial results for the fourth quarter and full year ended December 31, 2020, at 8:00 a.m. Eastern Time on Thursday, February 11, 2021. The call will follow the issuance of the Brighthouse Financial fourth quarter and full year 2020 earnings release and financial supplement on Wednesday, February 10, 2021, after market close.

To listen to the audio webcast via the internet and to access the related presentation, please visit the Brighthouse Financial Investor Relations web page at http://investor.brighthousefinancial.com. To join the conference call via telephone, please dial (844) 358-9117 (+1 (209) 905-5952 from outside the U.S.) and use conference ID 8498582.

A replay of the conference call will be made available until Friday, March 5, 2021, on the Brighthouse Financial Investor Relations web page at http://investor.brighthousefinancial.com.

About Brighthouse Financial, Inc.

Brighthouse Financial, Inc. (Brighthouse Financial) (Nasdaq: BHF) is on a mission to help people achieve financial security. As one of the largest providers of annuities and life insurance in the U.S.,1 we specialize in products designed to help people protect what they’ve earned and ensure it lasts. Learn more at brighthousefinancial.com.

1 Ranked by 2019 admitted assets. Best’s Review®: Top 200 U.S. Life/Health Insurers. A.M. Best, 2020.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210121005841/en/

Contacts

FOR INVESTORS
David Rosenbaum
(980) 949-3326
david.rosenbaum@brighthousefinancial.com

FOR MEDIA
Deon Roberts
(980) 949-3071
deon.roberts@brighthousefinancial.com

Latest Stories

  • Northern Trust Selected by Osmosis Investment Management to Support Fossil Fuel Free Common Contractual Fund

    Northern Trust today announced it has been selected by Osmosis Investment Management (Osmosis) to provide fund administration, global custody and depositary services for the Osmosis Resource Efficient Core Equity (ex-fossil fuels) Fund in a Collective Investment in Transferable Securities (UCITS) Common Contractual Fund (CCF).

  • Biden Announces Johnson & Johnson, Merck COVID Vaccine Collaboration in Wartime Effort

    President Biden announced the "type of collaboration between companies we saw in World War Two," with two competitors working together. Merck will help Johnson & Johnson produce its COVID vaccine,...

  • This Mini Foldable Trampoline Makes At-Home Cardio Fun — and It’s Nearly 50% Off

    Literally add some pep to your step

  • Susan Collins Will Vote For Interior Secretary Nominee Deb Haaland

    The Maine senator is the first Republican to support Biden's historic pick to lead the federal agency with oversight of public lands and tribal obligations.

  • SunOpta Announces Fourth Quarter Fiscal 2020 Financial Results

    SunOpta Inc. ("SunOpta" or the "Company") (Nasdaq:STKL) (TSX:SOY), a leading healthy food and beverage company focused on plant-based foods and beverages and fruit-based foods and beverages, today announced financial results for the fourth quarter ended January 2, 2021.

  • Cyber Apps Negotiating Acquisition of Scalable Work-From-Home HR Software Solution

    Las Vegas, Nevada--(Newsfile Corp. - March 3, 2021) - Cyber Apps World Inc. (OTC Pink: CYAP) ("Cyber Apps" or the "Company") (Cyberappsworld.com), an acquirer and developer of innovative cyber technologies with the potential for disruptive scalability and eventual spin-off success, is pleased to announce that the Company is currently in late-stage negotiations with a software development firm for the acquisition of a technology solution geared toward management of remote workers with an emphasis on ...

  • Pacira BioSciences to Present at the 2021 Barclays Global Healthcare Conference

    PARSIPPANY, N.J., March 03, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will present at the 2021 Barclays Global Healthcare Conference at 10:55 AM ET on Tuesday, March 9, 2021. Live audio of the virtual event can be accessed by visiting the “Events” page of the company’s website at investor.pacira.com. A replay of the webcast will also be available for two weeks following the event. About Pacira Pacira BioSciences, Inc. (Nasdaq: PCRX) is the industry leader in its commitment to non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. The company’s long-acting local analgesic, EXPAREL® (bupivacaine liposome injectable suspension) was commercially launched in the United States in April 2012. EXPAREL utilizes DepoFoam®, a unique and proprietary product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. In April 2019, Pacira acquired the iovera°® system, a handheld cryoanalgesia device used to deliver precise, controlled doses of cold temperature only to targeted nerves. To learn more about Pacira, including the corporate mission to reduce overreliance on opioids, visit www.pacira.com. CONTACT: Company Contact: Pacira BioSciences, Inc. Christian Pedetti (973) 254-4387 Christian.pedetti@pacira.com

  • G1 Therapeutics to Participate in Two Investor Conferences in March

    RESEARCH TRIANGLE PARK, N.C., March 03, 2021 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that the Company will participate in two investor conferences in March. Jack Bailey, G1’s Chief Executive Officer, will provide a presentation during the HC Wainwright Global Life Sciences Conference; this presentation will be available starting on March 9, 2021 at 7:00 AM ET. In addition, Mr. Bailey will also participate in a fireside chat during the Roth 33rd Annual Conference on March 17, 2021 at 10:30 AM ET. These conferences are being held virtually, and webcasts will be accessible on the Events & Presentations page of http://www.g1therapeutics.com. About G1 TherapeuticsG1 Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the discovery, development and delivery of next generation therapies that improve the lives of those affected by cancer, including the Company’s first commercial product COSELA™ (trilaciclib). G1 has a deep clinical pipeline evaluating targeted cancer therapies in a variety of solid tumors, including colorectal, breast, lung, and bladder cancers. G1 Therapeutics is based in Research Triangle Park, N.C. For additional information, please visit www.g1therapeutics.com and follow us on Twitter @G1Therapeutics. G1 Therapeutics is based in Research Triangle Park, N.C. For additional information, please visit www.g1therapeutics.com and follow us on Twitter @G1Therapeutics. Contacts:Will RobertsVice President, Investor Relations & Corporate Communications919-907-1944 wroberts@g1therapeutics.com

  • InflaRx to Present at Upcoming Investor Conferences

    InflaRx N.V. (Nasdaq: IFRX), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system, today announced that management will present at two upcoming virtual investor conferences. H.C. Wainwright Global Life Sciences ConferenceMarch 9-10, 2021An on-demand corporate presentation from Prof. Niels C. Riedemann, Chief Executive Officer and Founder of InflaRx, will be available starting at 7:00 am EST (1:00 pm CET) on March 9, 2021. A webcast of the event will be accessible on the InflaRx website in the Investors section under Events & Presentations. Oppenheimer 31st Annual Healthcare ConferenceTuesday, March 16, 2021 at 8:00 am EST (1:00 pm CET)A live webcasted corporate presentation from Prof. Riedemann will be available on the InflaRx website in the Investors section under Events & Presentations. A replay of the presentation will be accessible on InflaRx’s website following the live event. About InflaRx N.V.: InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a. Complement C5a is a powerful inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. InflaRx was founded in 2007, and the group has offices and subsidiaries in Jena and Munich, Germany, as well as Ann Arbor, MI, USA. For further information please visit www.inflarx.com. Contacts: InflaRx N.V.Jordan Zwick – Chief Strategy OfficerEmail: IR@inflarx.deTel: +1 917-338-6523 MC Services AGKatja Arnold, Laurie Doyle, Andreas JungferEmail: inflarx@mc-services.euEurope: +49 89-210 2280US: +1-339-832-0752 FORWARD-LOOKING STATEMENTS This press release contains forward-looking statements. All statements other than statements of historical fact are forward-looking statements, which are often indicated by terms such as “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “believe,” “estimate,” “predict,” “potential” or “continue” and similar expressions. Forward-looking statements appear in a number of places throughout this release and may include statements regarding our intentions, beliefs, projections, outlook, analyses and current expectations concerning, among other things, our ongoing and planned preclinical development and clinical trials; the impact of the COVID-19 pandemic on the Company; the timing and our ability to commence and conduct clinical trials; potential results from current or potential future collaborations; our ability to make regulatory filings, obtain positive guidance from regulators, and obtain and maintain regulatory approvals for our product candidates; our intellectual property position; our ability to develop commercial functions; expectations regarding clinical trial data; our results of operations, cash needs, financial condition, liquidity, prospects, future transactions, growth and strategies; the industry in which we operate; the trends that may affect the industry or us and the risks uncertainties and other factors described under the heading “Risk Factors” in InflaRx’s periodic filings with the Securities and Exchange Commission. These statements speak only as of the date of this press release and involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Given these risks, uncertainties and other factors, you should not place undue reliance on these forward-looking statements, and we assume no obligation to update these forward-looking statements, even if new information becomes available in the future, except as required by law.

  • Coty to Partner With LanzaTech to Pioneer New Sustainable Fragrance Production

    Coty to Partner With LanzaTech to Pioneer New Sustainable Fragrance Production

  • Aramark to Participate in Upcoming Bank of America Investor Conference

    Aramark (NYSE:ARMK), a global leader in food, facilities management and uniforms, announced that the Company’s Chief Executive Officer, John Zillmer, and Chief Financial Officer, Tom Ondrof, will participate in the virtual Bank of America Consumer and Retail Technology Conference on Wednesday, March 10th, 2021 with a featured Fireside Chat session beginning at 8:30 a.m. ET.

  • Tradeweb Reports February Total Trading Volume of $20.4 Trillion

    Tradeweb Markets Inc. (Nasdaq: TW), a leading, global operator of electronic marketplaces for rates, credit, equities and money markets, today reported total trading volume for February 2021 of $20.4 trillion (tn). Average daily volume (ADV) for the month was a record $1.06tn, an increase of 19.9 percent (%) year over year (YoY).

  • Sonic Automotive Inducted into Training Magazine Hall of Fame

    Sonic Automotive Inducted into Training Magazine Hall of Fame

  • ExxonMobil Outlines Plans to Grow Long-Term Shareholder Value in Lower Carbon Future

    ExxonMobil Outlines Plans to Grow Long-Term Shareholder Value in Lower Carbon Future

  • Dollar Tree, Inc. Reports Results for the Fourth Quarter and Fiscal Year 2020

    Dollar Tree, Inc. (NASDAQ: DLTR) today reported financial results for its fourth quarter and fiscal year ended January 30, 2021. Also, on March 2, 2021, Dollar Tree’s Board of Directors increased the Company’s share repurchase authorization by $2.0 billion. Under the authorization, purchases may be made in the open market or through privately negotiated transactions subject to market and other conditions. The authorization has no expiration date.

  • $33.6 Billion Worldwide Scientific Instruments Industry to 2027 - Impact of COVID-19 on the Market - ResearchAndMarkets.com

    The "Scientific Instruments - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

  • Display Market with COVID-19 Impact Analysis by Product, Resolution, Display Technology, Panel Size, Vertical, and Geography - Global Forecast to 2026

    Dublin, March 03, 2021 (GLOBE NEWSWIRE) -- The "Display Market with COVID-19 Impact Analysis by Product (Smartphones, Wearables, Television Sets, Signage, Tablets), Resolution, Display Technology (LCD, OLED, Direct-View LED, Micro-LED), Panel Size, Vertical, and Geography - Global Forecast to 2026" report has been added to ResearchAndMarkets.com's offering. The global display market size was valued at USD 148.4 billion in 2021 and is projected to reach USD 177.1 billion by 2026. It is expected to grow at a CAGR of 3.6% during the forecast period. Surging adoption of OLED displays in various applications, increasing use of LED displays for video wall, TVs, and digital signage applications, growing demand for interactive displays in various applications, and rising demand for display-based medical equipment, including ventilators and respirators, due to COVID-19 pandemic are the key driving factors for the display market. However, the decline in demand for displays in the retail sector due to the drastic shift towards online advertisement and shopping hampering the growth of the market. OLED technology to witness a higher CAGR during the forecast period OLEDs, due to their efficiency, superior color reproduction, and thin form factor, are expected to penetrate the television segment at a high rate during the forecast period. OLED panels for television sets are considerably more expensive to produce than modern LCD panels because of the lower yields of OLEDs. With improved yields, the prices of OLED television panels will decline rapidly. Using OLED panels in smartphones enables the production of highly bright light, low power consumption, and thin and lightweight form factor. Samsung Display is the leading producer of small and medium-sized active-matrix organic light-emitting diode (AMOLED) displays for smartphones and other devices. Samsung has utilized its AMOLED displays in its flagship smartphones, such as the Galaxy lineup. With Apple's adoption of AMOLED displays in its smartphones, the market witnessed exponential growth from 2018 to 2019, and the trend is expected to continue during the forecast period. Smart wearables to witness a higher CAGR during the forecast period The smart wearables display market segment is expected to witness high growth on the back of growing demand for HMDs. AR and VR HMDs are comparatively new products in the market and have a wide application scope across a number of industries. Smart wearable display devices and electronic screens have revolutionized the electronics industry by offering users interactive capabilities. Displays in such devices ideally require wide viewing angles, high resolution, high performance, optimum contrast, and high brightness. Researchers have come up with display technologies such as LCD, LCoS, OLED, and Micro-LED. APAC to account the largest share during 2021-2026 APAC is a leader in both production and consumption of display panels. The region has witnessed significant advancements in the display device market, along with rapid changes in terms of the adoption of new technologies. APAC will continue to witness a major demand for smartphone displays during the forecast period. Renowned smartphone vendors, including Samsung, Sony, Panasonic, Huawei, Xiaomi, Oppo, and Vivo, are based in the region. Apart from smartphone manufacturers, an increasing number of HMD manufacturers in APAC is also likely to raise the demand for display panels for smart wearable devices in the region during the forecast period. The display market in APAC is also expected to witness significant growth in the television, automotive display, and large format display segments during the forecast period. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights4.1 Attractive Growth Opportunities in Display Market4.2 Display Market, by Technology4.3 Display Market, by Product Type4.4 Display Market, by Panel Size4.5 Display Market, by Vertical4.6 Display Market, by Region 5 Market Overview5.1 Introduction5.2 Market Dynamics5.2.1 Drivers5.2.1.1 Surging Adoption of Oled Displays in Various Applications5.2.1.2 Increasing Use of Led Displays for Video Wall, Tvs, and Digital Signage Applications5.2.1.3 Growing Demand for Interactive Displays in Various Applications5.2.1.4 Rising Demand for Display-Based Medical Equipment, Including Ventilators and Respirators, due to COVID-19 Pandemic5.2.2 Restraints5.2.2.1 Decline in Demand for Displays from Retail Sector due to Drastic Shift Towards Online Advertisement and Shopping5.2.2.2 Deployment of Widescreen Alternatives, Such as Projectors and Screenless Displays, and Emergence of New Display Concepts5.2.3 Opportunities5.2.3.1 Growing Adoption of Foldable and Flexible Displays5.2.3.2 Rapid Adoption of Amoled Displays, Especially due to Introduction of 5G5.2.3.3 Emerging Use Cases of Displays to Provide Lucrative Growth Opportunities for Manufacturers5.2.3.4 Micro-Led and Mini-Led Technologies to Carve Out New Growth Avenues for Display Market5.2.3.5 Increased Capex Spending on Displays5.2.4 Challenges5.2.4.1 Hindrance in Supply Chain and Manufacturing Processes due to COVID-195.2.4.2 High Costs Associated with New Display Technology-Based Products5.3 Value Chain Analysis5.3.1 R&D5.3.2 Manufacturing5.3.3 Assembly and Integration5.3.4 Input Suppliers5.4 Display Ecosystem5.5 Pricing Analysis5.6 Patent Analysis5.7 Tariffs and Regulations Regarding Display Panel5.7.1 Key Regulations for Display Panel Market5.7.2 Tariffs: Display Panels5.8 Trade Analysis5.8.1 Export Scenario of Boards, Panels, Consoles, Desks, Cabinets, and Other Bases5.8.2 Import Scenario of Boards, Panels, Consoles, Desks, Cabinets, and Other Bases5.9 Case Studies5.9.1 Introduction5.9.2 Display in Restaurant5.9.3 Display for Corporate5.9.4 Display in Airport5.9.5 Display in Healthcare5.9.6 Display in Retail5.9.7 Display in Shopping Center5.9.8 Display in Hospitality 6 Display Market, by Resolution6.1 Introduction6.2 8K6.3 4K6.4 Fhd6.5 Hd6.6 Lower Than Hd 7 Display Market, by Display Technology7.1 Introduction7.2 Lcd7.2.1 Led-Lcd7.2.1.1 Led-Lcds Offer Advanced Features, Such as High Image Quality and Power Efficiency, Than Their Conventional Counterparts7.2.2 Qd-Lcd (Qdef-Lcd)7.2.2.1 Qd-Lcds are Mainly Used in Consumer Devices7.3 Oled7.3.1 Flexible7.3.1.1 Smartphones and Smart Wearables are Expected to Generate Substantial Demand for Flexible Oled Displays During Forecast Period7.3.2 Foldable7.3.2.1 Foldable Oled Displays are Set to Enable New Device Form Factors During Forecast Period7.3.3 Rigid7.3.3.1 Rigid Oled Panels are Usually Fabricated on Metal or Glass Substrates7.4 Micro-Led7.4.1 Micro-Led Display Panel Shipments to Surge Rapidly 2020 Onwards7.5 Direct-View Led7.5.1 Direct-View Fine-Pixel Led7.5.1.1 Falling Prices to Propel Adoption of Direct-View Fine-Pixel Led Displays During Forecast Period7.5.2 Direct-View Large-Pixel Led7.5.2.1 Large-Pixel Led Displays Find Major Applications in Outdoor Environment7.6 Others 8 Display Market, by Panel Size8.1 Introduction8.2 Microdisplays8.2.1 Microdisplays are Mainly Used in Cameras and Projectors8.3 Small and Medium-Sized Panels8.3.1 Small and Medium-Sized Display Panels are Predominantly Used in Small Devices8.4 Large Panels8.4.1 Large Display Panels are Mostly Used for Outdoor Applications 9 Display Market, by Product Type9.1 Introduction9.2 Smartphones9.2.1 Oled Displays to Dominate Smartphones Segment During Forecast Period9.3 Television Sets9.3.1 Oled Technology to Capture Major Share of Television Sets Segment During Forecast Period9.4 Pc Monitors & Laptops9.4.1 Lcd Technology to Hold Major Share of Pc Monitors & Laptops Segment During Forecast Period9.5 Digital Signage/Large Format Displays9.5.1 Large Format Displays are Mainly Used in Public Places, Transportation, Retail, and Outdoor Advertising9.6 Automotive Displays9.6.1 Oled Technology is Expected to Gain Traction in Automotive Displays During Forecast Period9.7 Tablets9.7.1 Oled Technology is Increasingly Being Used for Tablets9.8 Smart Wearables9.8.1 Smartwatch9.8.1.1 Oled Displays to Continue Dominating Smartwatch Segment During Forecast Period9.8.2 Ar Hmd9.8.2.1 Micro-Led to Emerge as Disruptive Display Technology in Ar-Hmd Segment During Forecast Period9.8.3 Vr Hmd9.8.3.1 Lcd Technology to Hold Major Share of Display Market for Vr Hmds During Forecast Period9.9 Others 10 Display Market, by Vertical10.1 Introduction10.2 Consumer10.2.1 Consumer Segment to Capture Largest Size of Display Market During Forecast Period10.3 Automotive10.3.1 Oled and Mini-Led Displays are Anticipated to be Extensively Adopted in Automotive Vertical During Forecast Period10.4 Sports & Entertainment10.4.1 Rapid Penetration of Ar/Vr Hmds into Sports and Entertainment Industries to Fuel Market Growth Driver During Forecast Period10.5 Transportation10.5.1 Transportation Vertical to Generate High Demand for Large Format Displays During Forecast Period10.6 Retail, Hospitality, and Bfsi10.6.1 Retail, Hospitality, and Bfsi Verticals to Adopt Digital Signage Displays at Large During Forecast Period10.7 Industrial & Enterprise10.7.1 Increasing Adoption of Ar/Vr Hmds to Drive Display Market Growth for Industrial and Enterprise Verticals10.8 Education10.8.1 Transition to Online Learning to Favor Growth of Display Market10.9 Healthcare10.9.1 Digitalization of Healthcare System to Propel Demand for Displays During Forecast Period10.10 Defnse & Aerospace10.10.1 Defense & Aerospace Segment to Exhibit Highest Growth in Display Market During Forecast Period10.11 Others 11 Geographic Analysis11.1 Introduction11.2 North America11.3 Europe11.4 APAC11.5 Rest of the World (Row) 12 Competitive Landscape12.1 Overview12.2 Market Share Analysis12.3 Revenue Analysis (Display Business)12.4 Market Evaluation Framework12.5 Company Evaluation Quadrant12.5.1 Star12.5.2 Emerging Leader12.5.3 Pervasive12.5.4 Participant12.6 Startup/SME Evaluation Matrix: Display Market12.6.1 Progressive Companies12.6.2 Responsive Companies12.6.3 Dynamic Companies12.6.4 Starting Blocks12.7 Competitive Scenario12.7.1 Product Launches/Developments12.7.2 Partnerships, Agreements, Contracts, Joint Ventures, and Collaborations12.7.3 Mergers & Acquisitions12.7.4 Expansions 13 Company Profiles13.1 Introduction13.2 Key Players13.2.1 Samsung Electronics13.2.2 LG Display13.2.3 Au Optronics (Auo)13.2.4 Boe Technology13.2.5 Sharp (Foxconn)13.2.6 Japan Display13.2.7 Innolux13.2.8 Sony13.2.9 Leyard Optoelectronics13.2.10 Qisda Corporation13.3 Right-To-Win13.4 Other Key Players13.4.1 NEC Corporation13.4.2 Tianma Microelectronics13.4.3 Universal Display13.4.4 Truly International13.4.5 Panasonic13.4.6 China Star Optoelectronics Technology (CSOT) (CDOT) (TCL)13.4.7 Chunghwa Picture Tubes13.4.8 Hannstar Display Corporation13.4.9 Emagin Corporation13.4.10 Kopin Corporation 14 Appendix14.1 Discussion Guide For more information about this report visit https://www.researchandmarkets.com/r/3o5s1 CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

  • Product and Regulatory Update on MedMira’s COVID-19 Product Family

    HALIFAX, Nova Scotia, March 03, 2021 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR) announces the expansion of its product portfolio and outlines the company’s COVID-19 market and regulatory plan. MedMira has utilized its patented Rapid Vertical Flow® (RVF®) technology and developed the company’s first rapid antigen test, VYRA CoV-2 Antigen Test (VYRA CoV-2), designed to detect SARS-CoV-2 virus in the swab samples. VYRA CoV-2 product expands the existing COVID-19 product family and directly addresses the wishes of our customers for an equally fast, reliable, and easy-to-use testing solution. VYRA CoV-2 saliva-based swab test is designed to be non-invasive and user-friendly, making this test more suitable for the home settings. “The successful development of this test opens up a new product line that has been a pioneering step for MedMira,” said Hermes Chan, CEO of MedMira. “With this we offer customers our COVID-19 product bundle that can accommodate various testing needs. For example, the VYRA CoV-2 can used to determine if the person is infected; REVEALCOVID-19™ PLUS [PLUS] tells if anti-SARS-CoV-2 antibodies are present; and our REVEALCOVID-19™ Nab-Y [Nab-Y] neutralizing test can potentially identify if the individual is immune to the virus.” With the FDA’s current focus on the development of the POC and home tests, MedMira received the pre-EUA submission number for its PLUS product to also include the POC claim. Once authorized by the FDA for distribution in the US, MedMira expects to maximize the sale potential in the current market environment. In preparation for the home test application, MedMira is now working on collecting additional performance data required by the Agency. MedMira will send the pre-EUA requests to seek the FDA authorization for REVEALCOVID-19™ Nab-Y and VYRA CoV-2 products, including the information required to support the POC claim. MedMira is working on the collaboration with the National Microbiology Lab to fulfill the additional requirements of the second Interim Order. In the meantime, MedMira’s REVEALCOVID-19™ Total Antibody Test is sold in the European Union and is highly valued by our European customers. About MedMiraMedMira is a leading developer and manufacturer of Rapid Vertical Flow® diagnostics. The Company’s tests provide hospitals, labs, clinics, and individuals with instant disease diagnosis, such as HIV, Syphilis, Hepatitis, and SARS-CoV-2, in just three easy steps. The Company’s tests are sold globally under the Reveal®, Multiplo® and Miriad® brands. Based on its patented Rapid Vertical Flow® Technology, MedMira’s rapid HIV test is the only one in the world to achieve regulatory approvals in Canada, the United States, China, and the European Union. MedMira’s corporate offices and manufacturing facilities are located in Halifax, Nova Scotia, Canada. For more information visit medmira.com. Follow us on Twitter and LinkedIn. This news release contains forward‐looking statements, which involve risk and uncertainties and reflect the Company’s current expectations regarding future events, including statements regarding possible regulatory approval, product launch, future growth, and new business opportunities. Actual events could materially differ from those projected herein and depend on a number of factors including, but not limited to, changing market conditions, successful and timely completion of clinical studies, uncertainties related to the regulatory approval process, establishment of corporate alliances and other risks detailed from time to time in the company quarterly filings. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. MedMira ContactsMarkus Meile, CFOTel: 902-450-1588Email: ir@medmira.com

  • The Global Polypropylene Fiber Market is expected to grow by $ 17.44 bn during 2021-2025, progressing at a CAGR of 6% during the forecast period

    Global Polypropylene Fiber Market 2021-2025 The analyst has been monitoring the polypropylene fiber market and it is poised to grow by $ 17. 44 bn during 2021-2025, progressing at a CAGR of 6% during the forecast period.New York, March 03, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Polypropylene Fiber Market 2021-2025" - https://www.reportlinker.com/p05772593/?utm_source=GNW Our report on polypropylene fiber market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing textile industry and rise in global construction and infrastructure development activities. In addition, growing textile industry is anticipated to boost the growth of the market as well.The polypropylene fiber market analysis includes end-user segment and geographical landscapes.The polypropylene fiber market is segmented as below:By End-user• Healthcare and hygiene• Geotextile• Construction• Furnishing• Other end-usersBy Geographical Landscapes• APAC• Europe• North America• MEA• South AmericaThis study identifies the increased consumption of hygiene products as one of the prime reasons driving the polypropylene fiber market growth during the next few years.The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on polypropylene fiber market covers the following areas:• Polypropylene fiber market sizing• Polypropylene fiber market forecast• Polypropylene fiber market industry analysisThis robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading polypropylene fiber market vendors that include ABC Polymer Industries LLC, BELGIAN FIBERS SA, Chemosvit AS, FORTA Corp., International Fibres Group Holdings Ltd., LCY Chemical Corp., Mapei SpA, Sika AG, The Euclid Chemical Co., and Zenith Fibres Ltd. Also, the polypropylene fiber market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.Read the full report: https://www.reportlinker.com/p05772593/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

  • A year after catastrophic Nashville tornado, music club owners set sights on reopening

    The 3 March storm killed more than 20 people, some in their beds, as it struck after midnight.